Takeda Pharmaceutical Company Limited Stock Börse Stuttgart
Stocks
TKDA
US8740602052
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.40 EUR | 0.00% |
|
0.00% | +9.92% |
| 07-08 | Takeda Pharmaceutical Completes Share Issuance, Disposal Under Incentive Plan | MT |
| 07-02 | Asian Equities Traded in the US as American Depositary Receipts Surge in Thursday Trading | MT |
| Market Cap | 8,467B 52.42B 45.85B 42.29B 39.06B 74.11B 4,999B 75.36B 505B 198B 2,463B 197B 193B | P/E 2027 * |
43.6x | P/E 2028 * | 27.9x |
|---|---|---|---|---|---|
| Enterprise Value | 12,352B 76.47B 66.89B 61.7B 56.98B 108B 7,294B 110B 737B 289B 3,593B 287B 281B | EV / Sales 2027 * |
2.67x | EV / Sales 2028 * | 2.6x |
| Free-Float |
99.26% | Yield 2027 * |
3.81% | Yield 2028 * | 3.89% |
Last Transcript: Takeda Pharmaceutical Company Limited
| Current month | +3.60% | ||
| 1 month | +5.11% | ||
| 3 months | -6.49% | ||
| 6 months | +3.60% | ||
| Current year | +9.92% |
| 1 week | 14.2 |  | 14.8 |
| 1 month | 13.1 | | 14.8 |
| Current year | 12.7 | | 16.2 |
| 1 year | 11.6 | | 16.2 |
| 3 years | 11.6 | | 16.2 |
| 5 years | 11.6 | | 16.2 |
| 10 years | 11.6 | | 18.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-06-23 | |
Mikuno Furuta
DFI | Director of Finance/CFO | 48 | 2024-03-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 47 | 2022-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Plump
BRD | Director/Board Member | 60 | 2015-05-31 |
Steven Gillis
BRD | Director/Board Member | 73 | 2018-12-31 |
Mikuno Furuta
BRD | Director/Board Member | 48 | 2024-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | - | - | 52.42B | |
| -2.33% | -2.09% | +49.88% | +169.76% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.56% | 619B | |
| -0.73% | -4.98% | +28.91% | +83.79% | 438B | |
| +0.33% | -1.17% | +31.07% | +26.57% | 333B | |
| -0.02% | -2.85% | +29.15% | +46.14% | 282B | |
| -3.89% | -11.22% | +22.81% | +25.23% | 267B | |
| +0.66% | -1.42% | -26.59% | -37.67% | 218B | |
| -0.06% | -2.88% | +23.07% | +61.02% | 196B | |
| -3.72% | -1.10% | +18.41% | +69.98% | 161B | |
| Average | -1.06% | -3.33% | +26.72% | +56.38% | 397.1B | |
| Weighted average by Cap. | -1.30% | -3.10% | +36.75% | +83.66% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 4,630B 28.67B 25.07B 23.13B 21.36B 40.53B 2,734B 41.21B 276B 109B 1,347B 108B 105B | 4,701B 29.1B 25.46B 23.48B 21.69B 41.15B 2,776B 41.84B 281B 110B 1,367B 109B 107B |
| Net income | 184B 1.14B 996M 919M 848M 1.61B 109B 1.64B 10.98B 4.31B 53.49B 4.27B 4.18B | 309B 1.91B 1.67B 1.54B 1.43B 2.71B 183B 2.75B 18.46B 7.25B 89.97B 7.19B 7.03B |
| Net Debt | 3,886B 24.06B 21.04B 19.41B 17.93B 34.01B 2,294B 34.59B 232B 91.07B 1,130B 90.32B 88.36B | 3,750B 23.22B 20.31B 18.73B 17.3B 32.83B 2,215B 33.38B 224B 87.9B 1,091B 87.18B 85.28B |
| Date | Price | Change |
|---|---|---|
| 26-07-10 | €14.40 | 0.00% |
| 26-07-09 | €14.40 | -1.37% |
| 26-07-08 | €14.60 | -1.35% |
| 26-07-07 | €14.80 | +0.68% |
| 26-07-06 | €14.70 | +2.08% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4502 Stock
- TKDA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
